In the case of heart failure patients who have highly increased norepinephrine content, β1-blocker treatment may raise this threshold, thereby protecting the cardiomyocytes from β-AR-induced apoptosis (Fig. 7). The gene discussed is ADRB2; the disease is heart failure.